AI Article Synopsis
- Cardiovascular disease significantly affects patients with autoimmune rheumatic diseases, leading to high rates of illness and death primarily due to systemic inflammation.
- Cardiac magnetic resonance imaging (MRI) is the most effective method for assessing heart structure and function, including detecting issues like inflammation and fibrosis.
- Advances in imaging techniques could improve the diagnosis and treatment of cardiovascular issues in these patients, and the paper suggests future applications of cardiac MRI in this area.
Article Abstract
Cardiovascular disease is the leading cause of morbidity and mortality in patients with autoimmune rheumatic diseases. Much of this may be attributed to systemic inflammation resulting in coronary atherosclerosis and myocarditis. Cardiac magnetic resonance imaging is the gold standard for the evaluation of cardiac structure and function, including tissue characterization, which allows for detection of myocardial edema, inflammation, and fibrosis. Advances in parametric mapping and coronary flow reserve measurement techniques have the potential to change the diagnosis, risk stratification, and management of patients with autoimmune rheumatic diseases. We provide an overview of the current evidence and suggest potential future roles for the use of comprehensive cardiac magnetic resonance in patients with autoimmune rheumatic diseases in the field of cardio-rheumatology.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156705 | PMC |
| http://dx.doi.org/10.1016/j.ijcha.2024.101381 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!